Gabapentin as an Adjuvant to Opioid Analgesia for Neuropathic Cancer Pain Augusto Caraceni, MD, Ernesto Zecca, MD, Cinzia Martini, MD, Franco De Conno,

Slides:

Advertisements

Similar presentations

Treatment of postherpetic neuralgia: a review of therapeutic options Charles E. Argoff, MD, Nathaniel Katz, MD, Miroslav Backonja, MD Journal of Pain and.

Advertisements

Spinal Cord and Peripheral Nerve Stimulation Techniques for Neuropathic Pain Oscar A. de Leon-Casasola, MD Journal of Pain and Symptom Management Volume.

Comparison of the Constipation Assessment Scale and Plain Abdominal Radiography in the Assessment of Constipation in Advanced Cancer Patients Kittiphon.

Palliative Medicine Fellowship: A Study of Resident Choices

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

Chronic Pain Management in Older Adults: Special Considerations

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Use of strong opioids in advanced cancer pain: a randomized trial

The Public Health Strategy for Palliative Care

An Assessment of the Safety, Eff icacy, and Acceptability of Intranasal Fentanyl Citrate in the Management of Cancer-Related Breakthrough Pain Giovambattista.

Effects of High Dose Opioids and Sedatives on Survival in Terminally Ill Cancer Patients Tatsuya Morita, MD, Junichi Tsunoda, MD, Satoshi Inoue, MD,

Chronic Pain Management in Older Adults: Special Considerations

Opioids for Cancer Breakthrough Pain: A Pilot Study Reporting Patient Assessment of Time to Meaningful Pain Relief Giovambattista Zeppetella, FRCP Journal.

Accuracy of a Diagnostic Algorithm to Diagnose Breakthrough Cancer Pain as Compared With Clinical Assessment Katherine Webber, MBBS, MSc, PhD, Andrew.

Pain Medication During Terminal Care of Children with Cancer

Evolution of Cancer-Related Symptoms Over an 18-Month Period

Optimization of opioid therapy for preventing incident pain associated with bone metastases Sebastiano Mercadante, MD, Patrizia Villari, MD, Patrizia.

Hospice and Palliative Care Development in India: A Multimethod Review of Services and Experiences Elizabeth McDermott, PhD, Lucy Selman, MPhil, Michael.

David M. Simpson, MD, Lydia Estanislao, MD, Stephen J

Patient-Controlled Analgesia With Intravenous L-Methadone in a Child With Cancer Pain Refractory to High-Dose Morphine Rainer Sabatowski, MD, Stefan.

Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients Laura L Adams, PhD, Robert.

What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study Catherine Malia, MSc, Michael I. Bennett, MB, ChB,

The Safety and Efficacy of a Single Dose (500 mg or 1 g) of Intravenous Magnesium Sulfate in Neuropathic Pain Poorly Responsive to Strong Opioid Analgesics.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

Studies Comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for Assessment of Pain Intensity in Adults: A Systematic Literature.

Double-Blind, Placebo-Controlled Trial of Lamotrigine in Combination with Other Medications for Neuropathic Pain Marianne Silver, MS, David Blum, MD,

Long-Term Safety of NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Peripheral Neuropathic Pain David M. Simpson, MD, Suzanne Gazda,

Frequency and Predictors of Patient Deviation From Prescribed Opioids and Barriers to Opioid Pain Management in Patients With Advanced Cancer Linh M.T.

Development and Initial Validation of the Three-Levels-of-Needs Questionnaire for Self- Assessment of Palliative Needs in Patients with Cancer Anna Thit.

Delirium in Terminal Cancer

Jean-Pierre Van Buyten, MD Journal of Pain and Symptom Management

What Can We Learn About the Spiritual Needs of Palliative Care Patients From the Research Literature? Mark Cobb, MA, Christopher Dowrick, MD, FRCGP,

David Clark, PhD, Michael Wright, PhD

From “Breakthrough” to “Episodic” Cancer Pain

Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD

Suresh K Joishy, MD, FACP, Declan Walsh, MSc, FACP

Evaluation of Methadone Absorption After Topical Administration to Hospice Patients Robert K. Sylvester, PharmD, Caroline Schauer, RN, John Thomas, MD,

Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms Anna-Liisa Kautio, MD, Maija Haanpää, MD, PhD, Tiina Saarto, MD, PhD, Eija.

Chronic opioid therapy for non-cancer pain

Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD

The effect of transdermal fentanyl treatment on serum cortisol concentrations in patients with non-cancer pain Emine Ozyuvaci, MD, Nergis Yanmaz Alnigenis,

Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD

Cancer Pain Assessment and Management Recommendations by Hospice Nurses Paul A Sloan, MD, Barbara L Vanderveer, BSN, Janet S Snapp, BSN, Mitzi Johnson,

Methadone Analgesia in Cancer Pain Patients on Chronic Methadone Maintenance Therapy Paolo L Manfredi, MD, Gilbert R Gonzales, Andrea L Cheville, Craig.

Improving Access to Opioid Analgesics for Palliative Care in India

Changing M3G/M6G Ratios and Pharmacodynamics in a Cancer Patient During Long- Term Morphine Treatment Gertrud Andersen, MD, Lona L Christrup, PhD, Per.

Cancer patient compliance in the self-administration of a pain assessment tool Augusto Caraceni, MD, Anna Galbiati, RN, Cinzia Brunelli, DSc, Giovanna.

The Spiritual Needs Assessment for Patients (SNAP): Development and Validation of a Comprehensive Instrument to Assess Unmet Spiritual Needs Rashmi K.

Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients? Filipa Tavares, MD Journal of Pain and Symptom.

The impact of demographic and disease-specific variables on pain in cancer patients Tone Rustøen, RN, PhD, Sophie D Fosså, MD, Dr Med Sci, Jon Skarstein,

Álvaro Sanz Rubiales, MD, PhD, Virginia de la Cruz, MD

Development and Reliability Testing of the Victoria Bowel Performance Scale (BPS) G. Michael Downing, MD, Craig Kuziemsky, PhD, Mary Lesperance, PhD,

Association Between Symptom Distress and Survival in Outpatients Seen in a Palliative Care Cancer Center J. Lynn Palmer, PhD, Michael J. Fisch, MD, MPH

The Impact of Delirium on the Circadian Distribution of Breakthrough Analgesia in Advanced Cancer Patients Bruno Gagnon, MD, Peter G. Lawlor, MB, Isabelle.

Gabapentin and an Opioid Combination Versus Opioid Alone for the Management of Neuropathic Cancer Pain: A Randomized Open Trial Kader Keskinbora, MD,

Effect of Recombinant Human Erythropoietin on Quality of Life in Cancer Patients Receiving Chemotherapy Gregoris Iconomou, PhD, Angelos Koutras, MD,

Ketamine Use for Reduction of Opioid Tolerance in a 5-Year-Old Girl with End-Stage Abdominal Neuroblastoma Doralina L. Anghelescu, MD, Linda L. Oakes,

The Asia Pacific Hospice Palliative Care Network

Assessing Delirium in Cancer Patients

Physical Function in Patients with Cancer

Predicting Place of Death of Elderly Cancer Patients Followed by a Palliative Care Unit Anna Maria Izquierdo-Porrera, MD, Jordi Trelis-Navarro, MD, Xavier.

Gerd Inger Ringdal, PhD, Marit S

Longitudinal Documentation of Cancer Pain Management Outcomes

Multidimensional independent predictors of cancer-related fatigue

Amy P. Abernethy, MD Journal of Pain and Symptom Management

Effectiveness of electroacupuncture analgesia compared with opioid administration in a dog model: a pilot study D. Groppetti, A.M. Pecile, P. Sacerdote,

Fatigue in Patients with Cancers of the Breast or Prostate Undergoing Radical Radiotherapy Patrick Stone, MA, MD, MRCP, Michael Richards, MA, MD, MRCP,

Episodic (Breakthrough) Pain Prevalence in a Population of Cancer Pain Patients. Comparison of Clinical Diagnoses With the QUDEI—Italian Questionnaire.

Use of Pregabalin in the Management of Chronic Uremic Pruritus

Presentation transcript:

Gabapentin as an Adjuvant to Opioid Analgesia for Neuropathic Cancer Pain Augusto Caraceni, MD, Ernesto Zecca, MD, Cinzia Martini, MD, Franco De Conno, MD Journal of Pain and Symptom Management Volume 17, Issue 6, Pages 441-445 (June 1999) DOI: 10.1016/S0885-3924(99)00033-0

Fig. 1 Mean and standard deviations of the pain scores at T0 (basal assessment) and T2 (1–2 weeks of gabapentin administration). *Student’s t test Journal of Pain and Symptom Management 1999 17, 441-445DOI: (10.1016/S0885-3924(99)00033-0)